News|Videos|April 9, 2025

Key Clinical Trial Insights from ACC 2025, with Deepak Bhatt, MD, MPH, MBA​

Fact checked by: Connor Iapoce

Deepak Bhatt, MD, MPH, MBA, explores high-impact trials from ACC.25, including REVERSE-IT, Alpaca, ADVANCE-HTN, SOUL, STRIDE, and DapaTAVI.

Thousands of cardiovascular professionals from around the world converged in Chicago for the American College of Cardiology’s 2025 Annual Scientific Session (ACC.25), where cutting-edge science and clinical breakthroughs took center stage. With more than 4,750 abstracts accepted, 1,300 expert faculty, and 53 late-breaking clinical trials, the meeting delivered a high-impact snapshot of where cardiology is headed.